1st Oct 2021 11:47
Immupharma PLC - London-based drug discovery and development company - Reports delisting from the Euronext Growth Brussels market, where it has a dual listing with London's AIM. The shares of Immupharma will be removed from trading on Euronext from October 18.
Current stock price: 7.78 pence
Year-to-date change: down 42%
By Evelina Grecenko; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Immupharma